Whole Body Cryotherapy

What it is

Whole body cryotherapy (WBC) involves brief exposure to extremely cold air (-110C to -140C) in a specialized chamber. Sessions last 2-4 minutes. Unlike cold water immersion (10-15C), WBC uses air cooled by electricity or liquid nitrogen to reach much lower temperatures.

How it works

The extreme cold triggers vasoconstriction followed by reactive vasodilation upon exiting the chamber. Norepinephrine levels increase 2-3x baseline. In animal models, cold exposure activates cold-shock proteins, particularly RBM3, which shows neuroprotective and synapse-preserving effects. Whether this translates to humans through WBC exposure is unconfirmed.

Evidence

Evidence is strongest for short-term muscle recovery and pain reduction in athletes. Multiple small RCTs support these effects. For longevity-specific outcomes, evidence is absent. No human studies have measured cold-shock protein activation, neuroprotection, or mortality outcomes with WBC. The gap between mechanistic plausibility (from animal cold exposure studies) and clinical evidence (from WBC specifically) remains wide.

Safety concerns

WBC carries real risks. Frostbite and cold burns can occur if protective gear for hands, feet, and ears is inadequate. Nitrogen-cooled chambers carry asphyxiation risk from oxygen displacement, and fatalities have been reported from improper operation. WBC is contraindicated in pregnancy, severe hypertension, cardiovascular disease, peripheral vascular disease, neuropathy, and cold-induced conditions. The FDA issued a consumer warning in 2016 noting the lack of evidence for medical claims and the potential risks.

Practical considerations

Commercial WBC sessions cost $30-80 per session. Typical protocols use 2-4 minute exposures 1-3 times per week. Home units are not widely available due to safety concerns. Compared to cold water immersion, WBC is more expensive but shorter in duration. The two approaches may activate different pathways, but head-to-head comparative data is limited.